Pioglitazone-induced myofibroblast cell death: implications for cutaneous scarring.
D016923:Cell Death / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002921:Cicatrix / Q000209:etiology; D005347:Fibroblasts / Q000187:drug effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000166:cytology / Q000187:drug effects; D000077205:Pioglitazone; D012871:Skin Diseases / Q000209:etiology; D045162:Thiazolidinediones / Q000494:pharmacology*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone